Malaysia Pharmaceuticals & Healthcare Report

Malaysia's pharmaceutical market will continue to expand over the medium-to-long term, driven by the rising demand for treatment for an ageing population and the introduction of new innovative therapies. The pandemic has underscored the need to increase funding for the healthcare system both in terms of facilities and working conditions for staff. In the 2022 budget, the Health Ministry has the second-largest allocation. Funds were set in the budget for the Covid-19 pandemic, improving public healthcare facilities and mental health support.